Biosite gets US nod for POC (point-of-care) chest pain screen
This article was originally published in Clinica
Executive Summary
The US FDA has given Biosite the green light to market its point-of-care (POC) Triage Cardio ProfilER blood test for helping to detect heart attack in patients with chest pain.